Cingulate

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$3.76
Previous Close
$3.82
Day Range
$3.65-$3.82
52W Range
$1.80-$20.83
Market Cap
$13.9M
Shares Short
133,391

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
-$10.1M
Diluted EPS
-$43.22

News

See more

Yahoo Finance • last year

Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update

Yahoo Finance • last year

Cingulate to Host CNS Key Opinion Leader Panel in New York City

Yahoo Finance • last year

Cingulate Announces Closing of $4.0 Million Public Offering

Yahoo Finance • 2 years ago

Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD

About

CEO
Dr. Shane J. Schaffer Pharm.D.
CFO
Ms. Jennifer L. Callahan CPA
Address
1901 West 47th Place, Kansas City, KS, United States, 66205
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
13